Medical Research

Trend Analysis: Politicized Health Science
Clinical & Pharma Trend Analysis: Politicized Health Science

In a move that signals a seismic shift in the relationship between public opinion and federal scientific priorities, the U.S. National Cancer Institute is now officially studying ivermectin, a drug that became one of the most polarizing symbols of the COVID-19 pandemic, as a potential cancer

NYU Langone Appoints New Radiation Oncology Chair
Clinical & Pharma NYU Langone Appoints New Radiation Oncology Chair

The landscape of cancer treatment is continually being reshaped by leaders who can seamlessly bridge the gap between groundbreaking research and compassionate patient care. In a significant move to further this evolution, NYU Langone Health has announced the appointment of Dr. Daniel R. Gomez, a

Is Direct-to-Patient the Future of Pharmacy?
Clinical & Pharma Is Direct-to-Patient the Future of Pharmacy?

A fundamental transformation is quietly reshaping the American pharmacy landscape, suggesting a future where the local drugstore might primarily dispense generic medications while complex, high-cost specialty drugs are delivered directly from the manufacturer to the patient's home. This emerging

How a Cave Experiment Revealed Our Biological Clock
Clinical & Pharma How a Cave Experiment Revealed Our Biological Clock

The intricate rhythm of day and night has governed life on Earth for eons, yet one French scientist’s daring descent into the planet’s depths revealed that a far more personal timepiece ticks within us all. In 1962, Michel Siffre embarked on a journey of self-experimentation that fundamentally

Are Processed Foods a Danger for Cancer Survivors?
Clinical & Pharma Are Processed Foods a Danger for Cancer Survivors?

For the ever-expanding community of individuals navigating life after a cancer diagnosis, dietary choices have long been recognized as a cornerstone of maintaining long-term health and mitigating the risk of recurrence. While conventional wisdom has traditionally emphasized the balance of

Funding Cuts Threaten Breakthrough Breast Cancer Research
Clinical & Pharma Funding Cuts Threaten Breakthrough Breast Cancer Research

In a laboratory at Harvard Medical School, rows of pink-lidded jars hold not just donated breast tissue samples, but the potential to prevent a disease that will affect one in eight American women. For years, this lab, led by renowned cancer researcher Dr. Joan Brugge, has been meticulously working

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later